Global platelet aggregation devices market is expected to reach USD 427.0 million by 2022, growing at a CAGR of 20.1% between 2017 and 2022.
The platelet aggregation devices market report includes comprehensive and profound analysis on the global and regional level. The report gives historic data of 2014 along with a forecast from 2017 to 2022 based on revenue (USD Million). The study comprises drivers, restraints, and opportunities for the platelet aggregation devices market along with the impact on the demand over the forecast period.
The report provides the complete view of the platelet aggregation devices market and encompasses detailed type portfolio and strategic developments of key vendors. To know the competitive landscape of the platelet aggregation devices market, an analysis of Porter’s five forces model is done. The study cover market attractiveness analysis, in which type segments are specialized based on the market size, growth rate, and attractiveness.
The report provides a crucial view on the platelet aggregation devices market by segmenting the market based on product, application, end-user and region. Based on product the platelet aggregation devices market is segmented into systems, reagents, consumables & accessories. Based on the application the platelet aggregation device market is segmented into clinical applications and research applications. On the basis of end-user, it is categorized into; standalone hospitals, research and academic institutes, diagnostic laboratories and other end users. All the segments have been analyzed based on existing and future trends and the market is projected from 2017 to 2022. The regional segmentation includes the present and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including China, Japan, India, U.S. Germany, France, UK, and Brazil.
The report presents comprehensive competitive outlook with company profiles of the key players operating in the global market. Key participants profiled in the report include Siemens AG, Helena Laboratories Corporation, Haemonetics Corporation, Accriva Diagnostics, F. Hoffman-La Roche Ltd, Helena Laboratories Corporation, Sysmex Corporation, Aggredyne, Inc., TEM Group, Sentinel Ch. S.P.A. among others.
This report segments the platelet aggregation devices market as follows:
Global Platelet Aggregation Devices Market: Product Segment Analysis
Global Platelet Aggregation Devices Market: Application Segment Analysis
Global Platelet Aggregation Devices Market: End-User Segment Analysis
Global Platelet Aggregation Devices Market: Regional Analysis
This report is based on in-depth qualitative and quantitative analyses of the global Platelet Aggregation Devices market. Zion Research has collected and analyzed key data belong to the global Platelet Aggregation Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Platelet Aggregation Devices across the world has been calculated through primary and secondary research.
Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Platelet Aggregation Devices industry. Primary research makes up the major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases, and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Platelet Aggregation Devices market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
Platelet aggregation devices market is expected to witness a significant growth owing to rising incidence of diseases such as dengue and malaria in Asia and a significant patient population undergoing surgeries across the world is expected to fuel the global platelet aggregation devices in coming five years. Platelets are types of blood cells which are also known as blood clot cells whose function is to stop bleeding by clumping and clotting blood vessel injuries. Without platelets, someone could bleed to death. Abnormal platelet aggregation leads to life-threatening disorders such as Glanzmann Thrombasthenia. Platelet aggregation disorder is hereditary or acquired. A platelet aggregation test checks how well the platelets clump together. Various medical devices are used to examine the platelet aggregation disorder. As per the centers for disease control and prevention (USA Gov.) hemophilia affects 1 in 5,000 male births and about 400 babies are born with hemophilia each year in U.S. In addition, age has a significant effect on platelet aggregation behavior so the geriatric population across the globe is expected to be one of the driving factors of the demand for platelet aggregation devices within the forecast period.
With the increasing number of platelet aggregation disorders, the demand for the platelet aggregation devices is increasing rapidly. In addition, major growth drivers for the platelet aggregation devices market are increasing the incidence of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometer within the forecast period. Furthermore, the demand for platelet aggregation devices is also expected to fuel by some other factors like increasing number of surgeries, increasing awareness and development of new technology in platelet aggregation devices market. In addition, increasing the incidence of disorders like; thrombocythemia; an abnormal increase in the number of platelets and thrombocytopenia; a decrease in the number of platelets) is expected to boost the demand for platelet function test market during the forecast period. However, the high cost of purchase, the dearth of well trained & skilled professionals and unfavorable healthcare reforms in the U.S. are expected to decelerate the growth in this market in coming five years. In spite of these restraints, research and development in the platelet devices market are expected to be an opportunity for this market in the forecast period.
On the basis of product, the global platelet aggregation devices market is categorized into; systems, reagents and consumables & accessories. In this segment, platelet aggregation systems dominated the market by accounting for the largest share of the global market in 2016. Major growth driver for the demand of systems includes continuous technological advancements in the field of sensors and detectors coupled with growing adoption & market preference for automated instruments among diagnostic laboratories.
On the basis of application, the platelet aggregation devices market segment is categorized into clinical applications and research applications. The application segment is expected to dominate by clinical applications owing to increasing awareness among healthcare professionals about the benefits of platelet healthcare devices supplemented by the increasing incidences of the target diseases. In addition, increasing geriatric population globally is also expected to boost the demand of these devices in the clinical application within the forecast period.
An end-user segment of the platelet aggregation devices market includes the: standalone hospitals, research and academic institutes, diagnostic laboratories and other end users. In this segment, standalone hospitals are expected to capture the largest market share of the global platelet aggregation devices market in coming five years owing to the benefits offered by hospitals in conducting the platelet aggregation testing procedure, large patient population base for diseases such as bleeding disorders, cardiovascular diseases, and arthritis.
North America accounted for largest share of this market in 2016 and is expected to witness the fastest growth in global platelet aggregation devices market in coming five years. U.S. had the largest market share in platelet aggregation devices market in this region. The North American region has become the attractive destination for platelet aggregation products manufacturing companies due to the large patient population for target diseases; a significant number of patients undergoing cardiovascular surgeries and increasing prevalence of urological and bleeding disorders.
Europe is expected to attribute for the second largest position in this market within the forecast period due to the presence of leading manufacturers of platelet aggregation devices in this region coupled with increasing rate of clinical research Furthermore, especially in Italy, a large number of people suffering from cardiovascular disease, neoplasm, and strokes are also expected to fuel the demand for platelet aggregation devices in this region in coming five years. Asia Pacific is expected to be one of the attractive markets for platelet aggregation devices within the forecast period owing to the increasing incidences of mosquito-borne diseases such as malaria and dengue.
Latin America is expected to show an above average growth due to increasing awareness among healthcare professionals related to the benefits of platelet aggregation testing in various diseases diagnosis. In the Middle East and South Africa, market growth for platelet aggregation devices is expected to boost by improving political stability and increasing awareness related to platelet disorders.
Some of the key players of green building market such as Siemens AG, Helena Laboratories Corporation, Haemonetics Corporation, Accriva Diagnostics, F. Hoffman-La Roche Ltd, Helena Laboratories Corporation, Sysmex Corporation, Aggredyne, Inc., TEM Group, Sentinel Ch. S.P.A. among others.